Citation Impact
Citing Papers
Why Is Longevity Still a Scientific Mystery? Sirtuins—Past, Present and Future
2022
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
An update on the regulatory mechanisms of NLRP3 inflammasome activation
2021
International Union of Basic and Clinical Pharmacology. XCV. Recent Advances in the Understanding of the Pharmacology and Biological Roles of Relaxin Family Peptide Receptors 1–4, the Receptors for Relaxin Family Peptides
2015
The NLRP3 inflammasome in acute myocardial infarction
2017
The Need for Standardized Assessment of Muscle Quality in Skeletal Muscle Function Deficit and Other Aging-Related Muscle Dysfunctions: A Symposium Report
2017
The role of inflammasomes in kidney disease
2019
Chronic inflammation in the etiology of disease across the life span
2019 Standout
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2018
Hepatocellular carcinoma
2021 Standout
Cancer-associated cachexia
2018 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies
2017
Inhibitory Effects of Toll-Like Receptor 4, NLRP3 Inflammasome, and Interleukin-1β on White Adipocyte Browning
2017
Adaptive immunity: an emerging player in the progression of NAFLD
2019
Development of covalent NLRP3 inflammasome inhibitors: Chemistry and biological activity
2018
Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
2020
Effects of MgSO4 on inhibiting Nod-like receptor protein 3 inflammasome involve decreasing intracellular calcium
2017
Physiological changes in pregnancy
2016 Standout
Sarcopenia
2019 Standout
Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment
2015
Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients
2015
Inflammation in obesity, diabetes, and related disorders
2022 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse
2019
The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?
2014
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
TLRs/NLRs: Shaping the landscape of host immunity
2017
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
The gut microbiota at the intersection of diet and human health
2018 Science
Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury
2018
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease
2017
Innate immunity as a target for acute cardioprotection
2018
The Controversial Role of Human Gut Lachnospiraceae
2020 Standout
White adipose tissue cells and the progression of cachexia: inflammatory pathways
2015
Skeletal muscle inflammation and insulin resistance in obesity
2017
The NLRP3 Inflammasome as a Pharmacological Target
2019
Works of Fausto Chiazza being referenced
Targeting the NLRP3 inflammasome to Reduce Diet-induced Metabolic Abnormalities in Mice
2015
Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice
2018
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis
2017
Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet‐Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice
2015
Accumulation of Advanced Glycation End-Products and Activation of the SCAP/SREBP Lipogenetic Pathway Occur in Diet-Induced Obese Mouse Skeletal Muscle
2015
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice
2015
Pharmacological Inhibition of NLRP3 Inflammasome Attenuates Myocardial Ischemia/Reperfusion Injury by Activation of RISK and Mitochondrial Pathways
2016
Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study
2018
High Sugar Intake and Development of Skeletal Muscle Insulin Resistance and Inflammation in Mice: A Protective Role for PPAR-δAgonism
2013
The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
2013
Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury
2013
P265 MICROPARTICLES RELEASED AS A CONSEQUENCE OF LIPID-INDUCED TOXICITY PROMOTE NLRP3 INFLAMMASOME ACTIVATION IN HepG2 CELLS
2014
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades
2020